Evidence map›Paper›PMID 40733298›Full record

ReviewMolecules (Basel, Switzerland)2025

Polymer-Based Mass Cytometry Reagents: Synthesis and Biomedical Applications.

Yin-Feng Wang, Wenying Wu, Ya-Hui Ge

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yin-Feng WangInstitute of Advanced Clinical Medicine, Biomedical Engineering Department, Peking University, Beijing 100191, China.
Wenying WuInstitute of Advanced Clinical Medicine, Biomedical Engineering Department, Peking University, Beijing 100191, China.ORCID 0000-0003-0074-6809
Ya-Hui GeInstitute of Advanced Clinical Medicine, Biomedical Engineering Department, Peking University, Beijing 100191, China.

Funding

the National Key R&D Program of China 2022YFC3401900
6 · The paper itself

Abstract

Mass cytometry has promoted the development of single-cell analysis by enabling the highly multiplexed detection of cellular markers using metal-tagged antibodies or cells. Polymer-based mass cytometry reagents have played a critical role in this technique due to their structural versatility, high metal-loading capacity, and sensitivity. This review comprehensively examines the advances in polymer-based reagents for mass cytometry, focusing on their design principles, synthetic strategies, and biomedical applications. We systematically analyze three key categories: metal-chelating polymers with macrocyclic/acyclic chelators developed through controlled polymerization techniques, polymeric particles including encoded microspheres and semiconducting polymer dots, and emerging metal-organic frameworks with high metal-loading capacities. The discussion highlights how these engineered materials overcome spectral limitations of conventional flow cytometry while addressing current challenges in sensitivity, and multiplexing capacity. Finally, we outline current challenges and future research directions for developing polymer probes in single-cell mass cytometry.

Indexed as

Flow CytometryPolymersSingle-Cell AnalysisAnimalsChelating AgentsHumansIndicators and ReagentsMetal-Organic FrameworksMicrospheresPolymerizationChelating AgentsIndicators and ReagentsMetal-Organic FrameworksPolymersmacrocyclic/acyclic chelatorsmass cytometrymetal-chelating polymersmetal–organic frameworkspolymeric particles

Identifiers

PMID40733298
PMCPMC12300974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.